Biotech News

Harmony Biosciences to Participate in Upcoming Investor Conferences

Harmony Biosciences (HRMY)Harmony BiosciencesConference / presentation

PLYMOUTH MEETING, Pa., Nov. 19, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that Harmony's management team will participate in the following upcoming investor conferences. 9 th Annual Evercore Healthcare Conference Location: Miami, FL Fireside Chat:

Related news

Harmony Biosciences

Sleep and Neurologic Disorders Harmony Biosciences develops and commercializes medicines for rare neurologic diseases. Its business is anchored by therapies that regulate wakefulness and sleep-wake signaling. WAKIX Franchise WAKIX, or pitolisant, is a histamine H3 receptor antagonist/inverse agonist used in narcolepsy and is the...

Recent company news

Stock data

Close
32.98 USD
Market cap
1.79B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States